Nurse’s Death in U.K. Linked to Weight Loss Drug Mounjaro
by Amber Baker
A 58-year-old nurse’s death has been linked to the popular weight loss drug tirzepatide, sold under the brand name Mounjaro. While her ...
GlaxoSmithKline Partners with Viome to Develop New Vaccines
by TVR Staff
Vaccine manufacturer GlaxoSmithKline (GSK) of the United Kingdom has partnered with Viome, a gut microbiome test company in Seattle, Washington ...
Novartis Manipulated Data in FDA Biologics License Application
by TVR Staff
On Aug. 6, 2019, the U.S. Food and Drug Administration (FDA) issued a statement saying that Swiss pharmaceutical company Novartis ...
Pfizer Fined Again for Violating Drug Laws
by Marco Cáceres
Colombia's national regulatory agency, the Superintendency of Industry and Commerce (SIC), has fined pharmaceutical company Pfizer $25,000 for allegedly inflating ...
Johnson & Johnson Fined $572 Million for “Greed” in Fueling the Opioid Crisis
by TVR Staff
In a lawsuit filed by the state of Oklahoma against Johnson & Johnson, Inc., Purdue Pharma LP and Teva Pharmaceutical ...
Google Joins the Pharmaceutical Industry
by Kate Raines
Story Highlights Google, the world’s most widely used internet search engine, restructured itself to give semi-independence to its many subsidiary ...
MMR Vaccine Sales Boost Merck’s 2019 Revenues
by TVR Staff
After the Centers for Disease Control and Prevention (CDC) publicized measles outbreaks in several states beginning in January 2019, on ...
Former FDA Commissioner Gottlieb Joins Pfizer
by TVR Staff
Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD has joined the board of directors of Pfizer, Inc.—the world's ...
Blockbuster Vaccine Sales Drive Higher Earnings for Merck
by Patrice La Vigne
Merck & Co., Inc. reported a strong financial start to 2019, with an eight percent increase in it first-quarter earnings, ...
In this section
Latest
Popular
Comments
Latest
Popular
Comments
- Lynn on Gates Foundation Awards $8.6 Million to Expand Development of Multi-Dose Pediatric Vaccines Using Novel Adjuvants
- Peace on Gates Foundation Awards $8.6 Million to Expand Development of Multi-Dose Pediatric Vaccines Using Novel Adjuvants
- Peace on Gates Foundation Awards $8.6 Million to Expand Development of Multi-Dose Pediatric Vaccines Using Novel Adjuvants
- Nan on Gates Foundation Awards $8.6 Million to Expand Development of Multi-Dose Pediatric Vaccines Using Novel Adjuvants
- Nick Quinlan on Gates Foundation Awards $8.6 Million to Expand Development of Multi-Dose Pediatric Vaccines Using Novel Adjuvants